Live BCG preparation
A therapeutic biological product intended for intravesical use. It is distinct from BCG vaccines used for tuberculosis prevention.
THERAPEUTIC BCG
BCG for Therapeutic Use
BCG for Therapeutic Use is a live BCG preparation administered by intravesical instillation under specialist supervision. The 60 mg/vial presentation is used in specified bladder tumour settings, including recurrence prevention after transurethral resection. Indications, dosing and safety information follow the approved label in each destination market.
- Product type
- Live BCG biological preparation
- Administration
- Intravesical instillation under specialist supervision
- Presentation shown
- 60 mg per vial; two vials per box
- Documentation
- Current label and market-specific regulatory status on request
PRODUCT PROFILE
Product at a glance
Therapeutic BCG is used in specialist bladder care. The approved label defines the indication, dosing and safety information for each product and market.
Specialist bladder care
Intravesical treatment is used in specified bladder tumour settings, including recurrence prevention after transurethral surgery. Clinical decisions follow the approved label.
60 mg per vial
The presentation shown has two vials per box. Formulation, shelf life and shipping conditions depend on the marketed product.
Market-specific review
Share the destination market, intended registration pathway, volume and documentation needs so we can review suitable supplier options.
PRODUCTION & QUALITY
Manufacturing capabilities ↗Explore partner capabilities
Learn how production, quality control and regulatory evidence are evaluated for vaccine projects.
Request product information
Tell us your destination market and what product, manufacturing and regulatory documents you need. We will confirm the applicable details for the selected supplier.